Anxiety disorder is the most common psychiatric disorder in the world [1] . Hence, scientists today focus more on improving anxiety disorders in clinical and/or laboratory settings. It should be noted that many regions of brain regulate anxiety related behaviors which include limbic system, prefrontal cortex and amygdala. The important role of septum and hippocampus in controlling anxiety has been widely reported in different studies [2, 3] . Anatomic and functional connections between hippocampus and septum have also been investigated by researchers [4, 5] . The septum and hippocampus act in concert to control anxiety and memory related behaviors. Glutamatergic, GABAergic, cholinergic and opioidergic neurons have been found between septum and hippocampus [6, 7] . These neurons and their activations interfere with anxiety behaviors.
Introduction
Anxiety disorder is the most common psychiatric disorder in the world [1] . Hence, scientists today focus more on improving anxiety disorders in clinical and/or laboratory settings. It should be noted that many regions of brain regulate anxiety related behaviors which include limbic system, prefrontal cortex and amygdala. The important role of septum and hippocampus in controlling anxiety has been widely reported in different studies [2, 3] . Anatomic and functional connections between hippocampus and septum have also been investigated by researchers [4, 5] . The septum and hippocampus act in concert to control anxiety and memory related behaviors. Glutamatergic, GABAergic, cholinergic and opioidergic neurons have been found between septum and hippocampus [6, 7] . These neurons and their activations interfere with anxiety behaviors.
Ablation or pharmacological inhibition of septum area reduces rats' anxiety-related behaviors in the elevated plus-maze test, suggesting that the septum normally plays an excitatory role in the control of anxiety [8, 9] . However, far less is known about the effects of inhibiting hippocampal activity on rats' anxiety reactions in these tests and the integrated role of the hippocampus and septum in regulating the expression of anxiety. One possibility is that the hippocampus makes a direct contribution to the excitatory role of the septum in regulating anxiety. The major hippocampal sub-regions, CA1, CA3 and the dentate gyrus have different anatomical relationships with the medial septum (MS). While each of these sub-regions receives ipsilateral projections from MS, only CA1 and CA3 project to the cholinergic and non-cholinergic neurons into MS [10] [11] [12] [13] . Reciprocal connections with MS suggest that CA1 and CA3 might be important components of the medial septum-hippocampal system. Histaminergic neurons in the nucleus tubermammillaris of the posterior hypothalamus innervate wide parts of the brain and spinal cord [14, 15] . Anxiety related stress may cause histamine release [16] . Histamine has strong effects on excitability in the hippocampus by acting on histamine H2 receptors and also affects the hippocampus indirectly through its projections on the MS which provide the cholinergic and non-cholinergic input to the hippocampus [17] [18] [19] . Our previous studies indicated that GABAergic system blockade in the MS attenuates anxiety-like behavior [6] . Herein, we aimed to investigate the histaminergic and GABAergic associations between dorsal hippocampus and MS, respectively. Moreover, the present study compares the power of two kinds GABA receptors, GABAA and GABAB receptors, in MS in anxiety related behavior of male rats.
Materials and Methods

Animals
Male Wistar rats (Pasteur Institute, Tehran, Iran) weighing 220 ± 20g at the time of surgery, were examined. The animals were housed four per cage, in a room with a 12:12 light/dark cycle (lights on 07:00 h) and controlled temperature (23 ± 1 C). Animals had free access to food and water and they were allowed to adapt to the laboratory conditions for at least 1 week prior to surgery. Seven animals were used in each group of experiments. The study was approved by Ethics committee of the Kharazmi University which corresponds to the national guidelines for animal care and use.
Stereotaxic surgery and microinjections
Rats were anesthetized intra-peritoneally with ketamine hydrochloride (50 mg/kg) and xylazine (4mg/kg) and placed in a Stoelting ste-http://www.mednifico.com/index.php/elmedj/article/view/119 reotaxic instrument (Stoelting Co, Illinois, and USA). The stainless steel guide cannula (22 gauge) was implanted in the dorsal hippocampus and medial septum. Stereotaxic coordinate for cannula implantation in the dorsal hippocampus was: anterocaudal: -3 to -3.5 mm (depending on body weight) anterior to bregma, ±1.8 to 2mm lateral to the midline, and -2.8 to -3mm ventral of the dorsal surface of the skull, according to the atlas of Paxinos and Watson [20] . The guide cannulas were anchored to the skull with two jewelers and acrylic dental cement. After surgery, rats were allowed seven days to recover from the operation.
The drug solutions were injected over a 1 minute period by means of internal cannula (27 gauge) connected by polyethylene tubing 25 ml Hamilton syringe and the cannula was left in place for an additional 1 min before being slowly withdrawn. The medial septum was injected with 1 µl solution over a 1 minute period.
Elevated plus-maze
The method is basically the same as described by Pellow et al, 1985 [21] . The elevated plus-maze is a wooden, cross-shaped maze, consisting of four arms arranged in the shape of a plus sign. Two of the arms have no side or end walls (open arms, 50×10 cm). The other two arms have side walls and end walls, but are open on the top (closed arms, 50×10×40 cm). Where the four arms intersect, there is a square platform of 10×10 cm. The maze was elevated to a height of 50 cm. In order to elevate total arm entries on the maze, rats were placed in a wooden test arena (50×50×35 cm) for 5 min prior to maze testing. Seven days after implantation, the effects of intra-CA1 injection of drugs were tested in the elevated plus-maze.
Animals were randomly allocated to treatment conditions and were tested in counterbalanced order. The rats were individually placed in the center of the maze facing a closed arm and allowed 5 min of free exploration. The number of entries into open arms, the number of entries into closed arms and the total time spent in the open arms and total time spent in the closed arms were measured. Entry was defined as all four paws in the arms and measured by hand counter.
The percentage of open arms entries and open arm times as the standard anxiety indices were calculated as follow: (a) %OAT (the ratio of times spent in the open arm to total times spent in any arms × 100); (b) %OAE (the ratio entries into open arms into total entries × 100); (c) Total closed arm entries were measured as a relative pure index of locomotor activity [22] .
Drugs
The drugs used in the present study were histamine dihydrochloride, baclofen and CGP34358, muscimol (Sigma, USA) and bicuculline (Ciba-Geiry, Switerland). All drugs were dissolved in sterile 0.9% saline, just before the experiment. Histamine was injected in a volume of 0.5 µl in each side of CA1 (1 µl/rat) although muscimol and bicuculline were unilaterally injected in a volume of 1 µl into medial septum. Total doses of the drugs were expressed as µg/rat. Control animals received 0.9% saline.
Drug treatment Experiment 1: effects of histamine in the CA1 on anxiety-like behavior
In this experiment, four groups of rats received saline (0.5 µl/side, 1 µl) or 3 different doses of histamine (1, 5 and 10 µg/rat, 0.5 µl/side). The test session was performed 5 min after intera-CA1 injections. %OAT, %OAE and locomotor activity were measured as described in the materials and method section.
Experiment 2: effects of histamine in the CA1 with muscimol in the MS on anxiety-like behavior
In this experiment, four groups of rats received saline (1 µl/rat) or 3 different doses of muscimol (2.5, 5 and 10 ng/rat). After that, four groups of rats received saline-saline (0.5 µl/side, 1 µl/rat intra hippocampal and 1 µl/rat intra septal) or subeffective doses of histamine (1 µg/rat, 0.5 µl/side) and muscimol (2.5 ng/rat) in the CA1 and MS, respectively. The test session was performed 5 min after intera-CA1 and intra-MS injections. %OAT, %OAE and locomotor activity were measured.
Experiment 3: effects of histamine in the CA1 with bicuculline in the MS on anxiety-like behavior
In this experiment four groups of rats received saline (0.5 µl/side , 1 µl/rat) or different doses of bicuculline (10, 20 and 30 ng/rat , intra medial septal). Four other groups of animals received histamine (10 mg/rat, intra-hippocampal) or different dose of bicuculline (10, 20 and 30 ng/rat , intra-medial septal) in the same time. The test session was performed 5 min after intra-hippocampal and intra septal injections.
Experiment 4: effects of histamine in the CA1 with baclofen in the MS on anxiety-like behavior
In this experiment four groups of rats received saline (0.5 µl/side, 1 µl/rat) or different doses of baclofen (0.1, 0.5 and 1 ng/rat, intra-medial septal). The test session was performed 5 min after intra-hipppcampal and intra-septal injections.
Experiment 5: effects of histamine in the CA1 with CGP35348 in the MS on anxiety-like behavior
In this experiment four groups of rats received saline (0.5 µl/side, 1 µl/rat) or different doses of baclofen (0.1, 0.5 and 1 ng/rat, intra-medial septal). Four other groups of animals received histamine (10 mg/rat, intra-hippocampal) or different dose of CGP35348 (5, 10 and 15 ng/rat, intra-medial septal) in the same time. The test session was performed 5 min after intra-hippocampal and intra-septal injections.
Statistical analysis
One-way ANOVA was used for comparison between the effects of different doses of histamine, muscimol and baclofen with its vehicle. Two-way ANOVA was used for evaluation of interactions between drugs. Following a significant F-value, post-hoc analysis (Tukey test) was performed for assessing specific group comparisons. Differences with P<0.05 between experimental groups at each point were considered statistically significant. Figure 1 illustrates the approximate point of the drugs injections in the CA1 and MS respectively. The histological results were plotted on representative sections taken from the rat brain atlas of Paxinos and Watson. Data from the animals with the injection sites located outside the CA1 and MS were not used in the analysis. This data indicates that histamine administration into CA1 induces an anxiolytic effect. Figure 2 shows the effects of MS injections of muscimol (2.5, 5 and 10 ng/rat) on anxiety-related parameters in the elevated plus-maze test. A one-way ANOVA revealed that muscimol at dose of 10 ng/rat (1µl/rat) also increased %OAT [F (3, 24) 
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Effects of histamine injection into CA1 on anxiety-like behavior
The effects of histamine injection into CA1 and muscimol injection into MS on anxiety-like behavior
Effects of histamine injection into CA1 and bicuculline injection into MS on anxiety-like behavior
Effects of histamine and bicuculline injection into CA1 and MS respectively on anxiety-like behavior are shown in figure 4 . A two-way ANOVA indicated a difference between the responses induced by bicuculline in the absence or presence of histamine. The data showed that intra-septal infusions of bicuculline selectively antagonizes the anxiolytic effects of intra-hippocampal histamine in the elevated plus-maze. No significant change in the locomotor activity was observed following administration of histamine alone or histamine plus bicuculline. Figure 5 shows the effects of MS injections of baclofen (0. .001], respectively) in the rats. Simultaneous injection of CGP35348 (15 ng/rat in MS) and histamine (1µg /rat into CA1) could increase the anxiolytic behavior synergically.
Effects of baclofen injection into MS on anxiety-like behavior
Discussion
The present results indicated that elevation of histamine level in the hippocampus and/or stimulating GABAergic receptors in the medial septum decreases anxiety as measured in the elevated plus maze test. Furthermore, the data suggests that concomitant stimulating hippocampal histaminergic and septal GABAergic receptors attenuate anxiety related behavior. Herein, we compared the anxiolytic potential of two GABA receptors, GABAA and GABAB receptors. The study has confirmed that stimulating GABAA agonist receptor using muscimol in the medial septum in connection with hippocampal histaminergic system has synergic effect on the anxiolytic related behavior. In contrast, GABAB receptor agonist, baclofen, did not have any significant changes alone and/or with simultaneous injection of histamine in the hippocampus. Administration of GABAA and GABAB receptors antagonists, bicuculine and CGP34358 respectively, established the anxiety regulative effects of these drugs.
The anxiolytic effects induced by stimulating the hippocampal histaminergic system are consistent with previous data indicating that intra-hippocampal infusions of histaminergic antagonists could increase anxiety [23] . Our results are also consistent with these data indicating histaminergic agents induce anxiolytic effects. The finding indicates that probably histamine in hippocampus through activation of GABAergic pathways toward septum and inhibition leads to decrease of anxiety. With respect to the septum, we have repeatedly found that ablation or pharmacological inhibition of this area reduces rats' anxiety-related behaviors in the elevated plus-maze and the shock-probe burying tests, suggesting that the septum normally plays an excitatory role in the control of anxiety [3, 9] . It has been reported that the GABA receptor mechanism can influence anxiety behavior in rats [24, 25] . In addition, the study confirmed that stimulating septal GABAergic receptors with a directly acting GABAA agonist, muscimol, can increase %OAT and %OAE but not locomotor activity. Thus, our study provides clear evidence that higher dose of muscimol in the MS decrease anxiety. The previous study also indicates that administration of muscimol into lateral and basal amygdale nuclei prior to anxiety conditioning or testing also reduces freezing in rats [26] . These findings indicate that probably muscimol through inhibition septum reduces anxiety. Our finding is also consistent with data indicating that muscimol injection into MS decreases anxiety [27] .
Overall, these results suggest that increasing histamine activity in the dorsal hippocampus reduces anxiety. The similarity of the anxiolytic effects of muscimol infused into the lateral and medial septum is consistent with lesion studies [28] . In addition, the present study shows that simultaneous stimulation of both hippocampal histaminergic and septal GABAergic receptors with sub-effective doses of above drugs results in a larger anxiolytic effect compared to the independent stimulation of each of these receptor systems.
Our central finding indicates that intra-septal infusions of bicuculline, a GABAA antagonist, selectively antagonizes the anxiolytic effect of intra-hippocampal histamine in the elevated plus-maze. It must be mentioned that if intra-septal bicuculline was anxiogenic, then this could mask any anxiolytic actions of intra-hippocampal histaminergic agent, regardless of whether these latter effects were ultimately due to reduced neurotransmission in a hippocampal projection target such as the septal nucleus or some other site. The results from our experiments strongly suggest that the hippocampus and the MS regulate open-arm exploration.
To investigate whether GABAB receptors are involved in anxiety related behavior, we injected baclofen (GABAB agonist) to the dorsal hippocampus. Baclofen decreased %OAT and %OAE in the elevated plus maze. Moreover, injection of CGP35348 (GABAB antagonist) reversed these changes in the rats. Concomitant injection of histamine and CGP35348 can induce anxiolytic effect more than a solitary injection of CGP35348. This different role of GABAB receptors might depend on their receptor site in the neuronal synapses [29] .
In summary, anxiolytic effect of GABAA receptor system in the MS region in the elevated plus-maze has been investigated. Histaminergic and GABAA systems act synergically for controlling anxiety. On the other hand, GABAB has anxiogenic effects in the medial septum. Taken together, it seems that anxiolytic effect of septohippocampus system may be modulated through GABAA receptors.
Conclusion
In summary, this report indicates that GABAA receptor has more effective potency in the septohippocampus system in the anxiety related behavior. In contrast, it has been showed that GABAB receptor has an anxiolytic effect in the medial septum. Hence, it can be concluded that hippocampal histaminergic systems act together via septum GABAergic system for regulating anxiety in male rats. 
